Pure Global

Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 130431. The device is manufactured by GeneReach Biotechnology Corp. from Taiwan, classified as In Vitro Diagnostic Device. The authorized representative in the UK is HORIBA UK Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 130431โ€ขRef: 130431

Device Type

In Vitro Diagnostic Device

Devices

Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Mar 16, 2024

Manufacturer Information

Address

No.19 Keyuan 2nd Road Xitun Dist.,

Taichung City 407, Taiwan

Created Date

Dec 31, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

KYOTO CLOSE MOULTON PARK

NORTHAMPTON, Northants, United Kingdom

Postcode: NN3 6FL

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing